Home
ELUT
ELUT News

Latest Elutia Inc. (ELUT) News on February 23, 2025

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

GlobeNewswire

2 days ago

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

Private equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9m

Simply Wall St.

15 days ago

Private equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9m

Elutia Announces $15.0 Million Registered Direct Offering

GlobeNewswire

20 days ago

Elutia Announces $15.0 Million Registered Direct Offering

Elutia announces full U.S. commercial launch of EluPro

TipRanks

a month ago

Elutia announces full U.S. commercial launch of EluPro

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand

GlobeNewswire

a month ago

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners

GlobeNewswire

2 months ago

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

GlobeNewswire

3 months ago

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

3 months ago

Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

GlobeNewswire

3 months ago

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

GlobeNewswire

3 months ago

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings

GuruFocus.com

3 months ago

What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

GlobeNewswire

4 months ago

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

GlobeNewswire

4 months ago

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

ACCESSWIRE

4 months ago

SWK Holdings Provides Portfolio Update

SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc

GuruFocus.com

4 months ago

SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

GlobeNewswire

5 months ago

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

Elutia Celebrates First Year

GlobeNewswire

6 months ago

Elutia Celebrates First Year

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

GlobeNewswire

6 months ago

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Elutia to Participate in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Elutia to Participate in Upcoming Investor Conferences

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Elutia Announces Second Quarter 2024 Results

GlobeNewswire

6 months ago

Elutia Announces Second Quarter 2024 Results

Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds

GlobeNewswire

7 months ago

Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

GlobeNewswire

7 months ago

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

GlobeNewswire

7 months ago

Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

ACCESSWIRE

7 months ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GlobeNewswire

7 months ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

Elutia to Present at the Emerging Growth Conference on Thursday, July 18

GlobeNewswire

7 months ago

Elutia to Present at the Emerging Growth Conference on Thursday, July 18

Individual investors in Elutia Inc. (NASDAQ:ELUT) are its biggest bettors, and their bets paid off as stock gained 16% last week

Simply Wall St.

8 months ago

Individual investors in Elutia Inc. (NASDAQ:ELUT) are its biggest bettors, and their bets paid off as stock gained 16% last week

Elutia Announces $13.26 Million Registered Direct Offering

GlobeNewswire

8 months ago

Elutia Announces $13.26 Million Registered Direct Offering

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

GlobeNewswire

8 months ago

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024

GlobeNewswire

9 months ago

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024

Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

GlobeNewswire

9 months ago

Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

GlobeNewswire

10 months ago

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

ACCESSWIRE

10 months ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

GlobeNewswire

10 months ago

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

Elutia Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

a year ago

Elutia Full Year 2023 Earnings: Misses Expectations

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

GlobeNewswire

a year ago

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

GlobeNewswire

a year ago

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants

News Direct

a year ago

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants

Analysts Estimate Regional Management (RM) to Report a Decline in Earnings: What to Look Out for

Zacks

a year ago

Analysts Estimate Regional Management (RM) to Report a Decline in Earnings: What to Look Out for

Bank7 Corp. (NASDAQ:BSVN) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Bank7 Corp. (NASDAQ:BSVN) Q4 2023 Earnings Call Transcript

GuruFocus.com

a year ago

FVCBankcorp Inc (FVCB) Reports Mixed Results Amidst Strategic Repositioning

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a year ago

FVCBankcorp (FVCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

Simply Wall St.

a year ago

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

Why WW International Stock Bounced 6% Higher Today

Motley Fool

a year ago

Why WW International Stock Bounced 6% Higher Today

Radcom (RDCM) Surges 5.4%: Is This an Indication of Further Gains?

Zacks

a year ago

Radcom (RDCM) Surges 5.4%: Is This an Indication of Further Gains?

Q1’s Rising Stars: 3 Lithium Stocks for Your Must-Watch List

InvestorPlace

a year ago

Q1’s Rising Stars: 3 Lithium Stocks for Your Must-Watch List

Elutia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

a year ago

Elutia Regains Compliance with Nasdaq Listing Requirements

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

GlobeNewswire

a year ago

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

AvePoint to Participate in 26th Annual Needham Growth Conference

GlobeNewswire

a year ago

AvePoint to Participate in 26th Annual Needham Growth Conference

CarParts.com, Inc. (NASDAQ:PRTS) is a favorite amongst institutional investors who own 62%

Simply Wall St.

a year ago

CarParts.com, Inc. (NASDAQ:PRTS) is a favorite amongst institutional investors who own 62%

Better Risky Investment: Bluebird Bio vs. Shiba Inu

Motley Fool

a year ago

Better Risky Investment: Bluebird Bio vs. Shiba Inu

Analysts Expect Breakeven For AvePoint, Inc. (NASDAQ:AVPT) Before Long

Simply Wall St.

a year ago

Analysts Expect Breakeven For AvePoint, Inc. (NASDAQ:AVPT) Before Long

Endeavour Silver Announces At-the-Market Offering of up to US$60 Million

GlobeNewswire

a year ago

Endeavour Silver Announces At-the-Market Offering of up to US$60 Million

12 High Growth Utility Stocks to Buy

Insider Monkey

a year ago

12 High Growth Utility Stocks to Buy

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance

GlobeNewswire

a year ago

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance

Insider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)

GuruFocus.com

a year ago

Insider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)

Climb Channel Solutions Expands Malwarebytes Partnership to North America, Providing MSPs and Resellers with Award-Winning Endpoint Security

GlobeNewswire

a year ago

Climb Channel Solutions Expands Malwarebytes Partnership to North America, Providing MSPs and Resellers with Award-Winning Endpoint Security

Townsquare To Participate In Upcoming Investor Conferences

GlobeNewswire

a year ago

Townsquare To Participate In Upcoming Investor Conferences

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES

CNW Group

a year ago

VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS ON THE COPALA AND COPALA 2 STRUCTURES

Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues

Simply Wall St.

a year ago

Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues

NuScale Power to Collaborate with Oak Ridge National Laboratory for a Techno-Economic Assessment

Business Wire

a year ago

NuScale Power to Collaborate with Oak Ridge National Laboratory for a Techno-Economic Assessment

Atomera Achieves Revenue Milestone Under First Commercial License Agreement

ACCESSWIRE

a year ago

Atomera Achieves Revenue Milestone Under First Commercial License Agreement

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

CNW Group

a year ago

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

GlobeNewswire

a year ago

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Docebo Reports Third Quarter 2023 Results

Business Wire

a year ago

Docebo Reports Third Quarter 2023 Results

Associated Press Finance

a year ago

Kandi Tech: Q3 Earnings Snapshot

GlobeNewswire

a year ago

Kandi Technologies Reports Third Quarter 2023 Financial Results

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

GlobeNewswire

a year ago

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

Tile Shop Holdings, Inc. (NASDAQ:TTSH) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Tile Shop Holdings, Inc. (NASDAQ:TTSH) Q3 2023 Earnings Call Transcript

New Report: Virtual Events Surpass Both Hybrid and In-Person Events

GlobeNewswire

a year ago

New Report: Virtual Events Surpass Both Hybrid and In-Person Events

Share on Social Networks: